Sandro Pignata
0000-0002-8836-2633
4 papers found
Refreshing results…
Reply to Z.R. McCaw et al
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
A European, observational, prospective trial of trabectedin plus pegylated liposomal doxorubicin in patients with platinum‐sensitive ovarian cancer
Missing publications? Search for publications with a matching author name.